Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tongjingling granules
- Development stage
- Unknown
- Lead developer
- Beijing Asia-East Bio-Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongjingling Granules (痛经灵颗粒) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Beijing ASIA-EAST Biopharmaceutical (Beijing Yadong Biopharmaceutical). It is an approved pharmaceutical in China, specifically indicated for the treatment of dysmenorrhea (painful menstruation) within the field of gynecology. The formulation is based on TCM principles of 'activating blood circulation to dissipate blood stasis' and 'regulating Qi to alleviate pain.' It typically contains a combination of herbal extracts such as Angelica sinensis, Corydalis yanhusuo, and Cyperus rotundus, which work synergistically to reduce uterine smooth muscle spasms and inhibit inflammatory mediators. The product is intended for patients whose dysmenorrhea is characterized by Qi stagnation and blood stasis, often presenting with abdominal pain and menstrual clots.
- Brand names
- Tongjingling Keli
- Other names
- 痛经灵颗粒Tongjingling Granules
02
Targets
COX
Beyond the preview
Go deeper on tongjingling granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tongjingling granules.